GRCL - Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.02
- Gracell Biotechnologies press release ( NASDAQ: GRCL ): Q2 GAAP EPS of -$0.06 beats by $0.02 .
- As of June 30, 2022, the Company had RMB1,707.3 million (US$254.9 million) in cash and cash equivalents and short-term investments. In addition,
For further details see:
Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.02